US2011245501A1PendingUtilityA1
Substituted Tetracycline Compounds as Synergistic Antifungal Agents
Est. expiryMar 14, 2021(expired)· nominal 20-yr term from priority
A61P 37/04A61P 43/00A61K 31/65A61K 45/06A61P 31/10A61K 31/7048A61P 29/00A61P 31/18
51
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to substituted tetracycline compounds and related methods for increasing the antifungal activity of an antifungal agent. The methods include administering to a subject an effective amount of a substituted tetracycline compound in combination with an antifungal agent such that the subject is treated for the fungal associated disorder.
Claims
exact text as granted — not AI-modified1 . A compound selected from the group consisting of:
and pharmaceutically acceptable salts and enantiomers thereof.
2 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
3 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
4 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
5 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
6 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
7 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
8 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
9 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
10 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
11 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
12 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
13 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
14 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
15 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
16 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
17 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
18 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
19 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.
20 . The compound of claim 1 , wherein said compound is:
or a pharmaceutically acceptable salt or enantiomer thereof.Join the waitlist — get patent alerts
Track US2011245501A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.